Pennington Biomedical Research Center researchers at the Metamor Institute, along with colleagues from Our Lady of the Lake and LSU Health-New Orleans, have recently determined that metabolic surgery on patients with heart failure can result in a reduction in the need for oral diuretics, which are used to manage symptoms such as venous and vascular pressures. The researchers explain their processes and elaborate on their findings in the recent study "Clinical Outcomes of Metabolic Surgery on Diuretic Use in Patients with Heart Failure," published in The American Journal of Cardiology . While obesity is widely recognized as a co-morbidity of heart failure, strong evidence suggests that obesity is a leading cause of the condition.
The authors hypothesized that metabolic surgery may reduce recurrence of heart failure symptoms. Researchers reviewed more than 2,300 hospital records of patients who underwent metabolic surgery between 2017 and 2023 and identified 63 of those patients with a diagnosis of heart failure prior to surgery. "The data unearthed in our study further expands the extended benefits of metabolic surgery, including for those with heart failure and heart disease ," said Dr.
Philip Schauer, Director of the Metamor Institute, located on the campus of Pennington Biomedical Research Center in Baton Rouge, and one of the researchers on the study. "With obesity as a commonly occurring factor in heart failure, the reduction in the use of diuretics following metabolic su.
